Canning P, Cooper CDO, Krojer T et al (2013) Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. J Biol Chem. https://doi.org/10.1074/jbc.M112.437996
Article PubMed PubMed Central Google Scholar
2.Chi SN, Gardner SL, Levy AS et al (2004) Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. https://doi.org/10.1200/JCO.2004.12.126
3.Choque-Velasquez J, Resendiz-Nieves JC, Jahromi BR et al (2019) Pineal parenchymal tumors of intermediate differentiation: a long-term follow-up study in Helsinki neurosurgery. World Neurosurg. https://doi.org/10.1016/j.wneu.2018.10.128
4.Committee of Brain Tumor Registry of Japan (2017) Report of brain tumor registry of Japan (2005–2008). Neurol Med Chir (Tokyo). https://doi.org/10.2176/nmc.sup.2017-0001
5.de Kock L, Priest JR, Foulkes WD et al (2020) An update on the central nervous system manifestations of DICER1 syndrome. Acta Neuropathol. https://doi.org/10.1007/s00401-019-01997-y
6.de Kock L, Sabbaghian N, Druker H et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol. https://doi.org/10.1007/s00401-014-1318-7
Article PubMed PubMed Central Google Scholar
7.Duregon E, Cassenti A, Pittaro A et al (2015) Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Neuro Oncol. https://doi.org/10.1093/neuonc/nov002
Article PubMed PubMed Central Google Scholar
8.Esbenshade AJ, Kocak M, Hershon L et al (2017) A phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): a report from the Children’s Oncology Group. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.26373
Article PubMed PubMed Central Google Scholar
9.Fauchon F, Jouvet A, Paquis P et al (2000) Parenchymal pineal tumors: a clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/s0360-3016(99)00389-2
10.Fevre-Montange M, Vasiljevic A, Frappaz D et al (2012) Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study. Neuropathol Appl Neurobiol. https://doi.org/10.1111/j.1365-2990.2011.01202.x
11.Friedrich C, von Bueren AO, von Hoff K et al (2013) Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol. https://doi.org/10.1093/neuonc/nos292
12.Gajjar A, Chintagumpala M, Ashley D et al (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. https://doi.org/10.1016/s1470-2045(06)70867-1
13.Gerber NU, von Hoff K, Resch A et al (2014) Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2014.04.017
Article PubMed PubMed Central Google Scholar
14.Gururangan S, McLaughlin C, Quinn J et al (2003) High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol. https://doi.org/10.1200/JCO.2003.10.096
15.Ito T, Kanno H, Sato K et al (2014) Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation. World Neurosurg. https://doi.org/10.1016/j.wneu.2013.02.007
16.Jakacki RI, Burger PC, Kocak M et al (2015) Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.25405
Article PubMed PubMed Central Google Scholar
17.Jouvet A, Saint-Pierre G, Fauchon F et al (2000) Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol. https://doi.org/10.1111/j.1750-3639.2000.tb00242.x
18.Jouvet A, Vasiljevic A, Nakazato Y et al (2016) Tumours of the pineal region. In: Louis D (ed) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 170–182
19.Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. https://doi.org/10.1038/bmt.2012.244
Article PubMed PubMed Central Google Scholar
20.Korogi Y, Takahashi M, Ushio Y (2001) MRI of pineal region tumors. J Neurooncol. https://doi.org/10.1023/a:1012773727022
21.Kumar N, Srinivasa GY, Madan R et al (2018) Role of radiotherapy in residual pineal parenchymal tumors. Clin Neurol Neurosurg. https://doi.org/10.1016/j.clineuro.2018.01.027
22.Lee JC, Mazor T, Lao R et al (2019) Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol. https://doi.org/10.1007/s00401-019-01990-5
Article PubMed PubMed Central Google Scholar
23.Li BK, Vasiljevic A, Dufour C et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a rare brain tumor consortium registry study. Acta Neuropathol. https://doi.org/10.1007/s00401-019-02111-y
Article PubMed PubMed Central Google Scholar
24.Liu APY, Gudenas B, Lin T et al (2020) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. https://doi.org/10.1007/s00401-019-02106-9
Article PubMed PubMed Central Google Scholar
25.Mallick S, Benson R, Rath GK (2016) Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis. Radiother Oncol. https://doi.org/10.1016/j.radonc.2016.10.025
26.Mynarek M, Pizer B, Dufour C et al (2017) Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US head start data. Neuro-Oncol. https://doi.org/10.1093/neuonc/now234
27.Northcott PA, Buchhalter I, Morrissy AS et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature. https://doi.org/10.1038/nature22973
Article PubMed PubMed Central Google Scholar
28.Parikh KA, Venable GT, Orr BA et al (2017) Pineoblastoma-the experience at St. Jude Children’s Research Hospital. Neurosurgery. https://doi.org/10.1093/neuros/nyx005
29.Pfaff E, Aichmuller C, Sill M et al (2020) Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. Acta Neuropathol. https://doi.org/10.1007/s00401-019-02101-0
30.Raleigh DR, Solomon DA, Lloyd SA et al (2017) Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro Oncol. https://doi.org/10.1093/neuonc/now105
Article PubMed PubMed Central Google Scholar
31.Tsumanuma I, Tanaka R, Washiyama K (1999) Clinicopathological study of pineal parenchymal tumors: correlation between histopathological features, proliferative potential, and prognosis. Brain Tumor Pathol. https://doi.org/10.1007/BF02478904
32.Yu T, Sun X, Wang J et al (2016) Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2014-309805
33.Zhu P, Zhang CB, Yang P et al (2016) Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas. Oncotarget. https://doi.org/10.18632/oncotarget.7154
留言 (0)